hepatitis b vaccine (recombinant) (recombivax) Report issue

Active Ingredient History

NOW
  • Now
Hepatitis B vaccine is a vaccine that prevents hepatitis B. The first dose is recommended within 24 hours of birth with either two or three more doses given after that. This includes those with poor immune function such as from HIV/AIDS and those born premature. It is also recommended that health-care workers be vaccinated. In healthy people routine immunization results in more than 95% of people being protected.   Wikipedia

More Chemistry
adjuvanted hepatitis b vaccine | hbsag | hbvaxpro | hb vax pro | hbv surface antigen | hbv vaccin | hbv vaccine | hepatitis b antigen | hepatitis b antigen peptide | hepatitis b, recombinant surface antigen | hepatitis b surface antigen | hepatitis-b surface antigen | hepatitis b surface antigen (rdna) | hepatitis b surface antigen (recombinant) | hepatitis b surface antigens | hepatitis b surface antigen vaccine | hepatitis b vaccine | hepatitis b vaccine (recombinant) | hepatitis b virus hbsag surface protein antigen | hepatitis b virus vaccine | hep b vaccine | heplisav | heptatis b surface antigen | recombinant hbv vaccine | recombinant hepatitis b vaccine | recombivax | recombivax hb | twinrix

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue